Breast cancer is one of the most common malignant tumors in women, which poses a great threat to women's life and health.In recent years, as people pay more attention to women's health, the detection methods of their diseases have been greatly improved.Breast cancer tests include screening tests, diagnostic tests and monitoring tests.Screening tests, such as annual mammograms, are given regularly to people who appear healthy and who are not suspected of having breast cancer.The goal is to detect breast cancer early, before any symptoms appear, and cancer is often easier to treat.Diagnostic tests (such as biopsies) are for people suspected of having breast cancer (such as biopsies).These tests are used to determine whether breast cancer is present and, if so, whether it has reached the outside of the breast.Diagnostic tests are also used to gather more information about cancer to guide treatment decisions.Once breast cancer is diagnosed, many tests are used during and after treatment to monitor how well therapies are working. Monitoring tests also may be used to check for any signs of recurrence.
This report contains market size and forecasts of Breast Cancer Testing in Global, including the following market information:
Global Breast Cancer Testing Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Breast Cancer Testing market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Screening Tests Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Breast Cancer Testing include Abbott, Alere, Becton Dickinson, BioMerieux, Roche, GE Healthcare, Hologic, Philips and PerkinElmer and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Breast Cancer Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Breast Cancer Testing Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Breast Cancer Testing Market Segment Percentages, by Type, 2021 (%)
Screening Tests
Diagnostic Tests
Monitoring Tests
Global Breast Cancer Testing Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Breast Cancer Testing Market Segment Percentages, by Application, 2021 (%)
Non-invasive Breast Cancer
Invasive Breast Cancer
Global Breast Cancer Testing Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Breast Cancer Testing Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Breast Cancer Testing revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Breast Cancer Testing revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott
Alere
Becton Dickinson
BioMerieux
Roche
GE Healthcare
Hologic
Philips
PerkinElmer
Quest Diagnostics